The results showed that the knockdown of DOR significantly increased BACE1 activities both under physiological and AD injury conditions (a significant increase by 86.6% vs. the control group, p < 0.01, a rise by 54.8% vs. “A” group after 48-h exposure, p < 0.001, Figure 5A). This evidence concerns the gene BACE1 and Alzheimer disease.